image: compassphs

Are expensive cancer drugs being approved without enough proof that they work?

October 6, 2017


Recent research indicates that only half of the cancer drugs approved by the European Medicines Agency (EMA) showed benefit in patients.

Since most cancer drugs cost about $100,000 per patient per year, it is not surprising that cancer is one of the most costly diseases to treat. The global budget for cancer treatment is around $895 billion a year. With extensive research to beat cancer, new treatments with claims of extended survival are frequently being made available. Understandably, cancer patients all want access to them so they can enjoy life for longer, yet these news drugs typically carry the highest price tags. But exactly what benefits do they provide?

Read More on The Medical News